The chemical class known as FXYD2 activators encompasses a diverse range of compounds and factors that have been investigated for their potential to modulate the activity or expression of the FXYD2 protein. FXYD2, also referred to as the sodium-potassium pump regulatory subunit alpha-2 or the gamma subunit of Na,K-ATPase, plays a critical role in the regulation of the sodium-potassium pump (Na,K-ATPase) in various tissues, including the heart and kidney. FXYD2 activators are characterized by their capacity to influence the function of the Na,K-ATPase pump through interactions with the FXYD2 subunit. These interactions can lead to alterations in sodium and potassium transport across cell membranes, impacting cellular ion homeostasis. The activators within this class can exhibit a variety of mechanisms through which they exert their effects. Some activators may directly bind to FXYD2, inducing conformational changes that enhance the efficiency of Na,K-ATPase-mediated ion transport. Others may act indirectly, affecting signaling pathways that regulate FXYD2 expression or phosphorylation status.
The activators can vary widely in terms of their chemical structures. They may include small organic molecules, ions, or even larger biomolecules. Substances such as hormones, such as aldosterone and angiotensin II, have been studied for their ability to enhance FXYD2 expression, contributing to the fine-tuning of ion transport in response to physiological cues. Similarly, environmental factors like hypoxia and hypertonicity can stimulate FXYD2 expression, reflecting the adaptability of cells to changing conditions. Protein kinases, including PKA and PKC, have been implicated in FXYD2 regulation, with certain activators potentially triggering phosphorylation events that modify FXYD2 activity. Additionally, dietary factors, such as salt intake and potassium levels, can influence FXYD2 expression, hinting at the intricate interplay between diet and ion balance.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aldosterone | 52-39-1 | sc-210774 sc-210774A sc-210774B sc-210774C sc-210774D sc-210774E | 2 mg 5 mg 10 mg 50 mg 100 mg 250 mg | $259.00 $213.00 $317.00 $1550.00 $3074.00 $7637.00 | 1 | |
Aldosterone is a hormone that regulates sodium and potassium balance in the body. It has been shown to increase the expression of FXYD2 in renal tubular cells, leading to enhanced sodium reabsorption. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II, a peptide hormone, can stimulate FXYD2 expression in cardiac tissues, potentially contributing to the regulation of sodium and potassium transport in the heart. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain is a cardiac glycoside that can activate Na,K-ATPase. It has been studied for its potential to affect FXYD2 expression and activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a β-adrenergic receptor agonist that can influence FXYD2 expression and function in the heart. | ||||||